z-logo
open-access-imgOpen Access
Adherence to Hospital Antibiotic Policy for Treatment of Escherichia coli ESBL in Urine
Author(s) -
R. Someshwaran,
K Gnana Prakash,
Shreeram A Deshpande,
Anbu N Aravazhi
Publication year - 2016
Publication title -
journal of clinical and diagnostic research
Language(s) - English
Resource type - Journals
eISSN - 2249-782X
pISSN - 0973-709X
DOI - 10.7860/jcdr/2016/16084.7382
Subject(s) - medicine , antibiotics , urinary system , ciprofloxacin , norfloxacin , escherichia coli , ofloxacin , antibiotic resistance , intensive care medicine , microbiology and biotechnology , biology , biochemistry , gene
Escherichia coli are the most common uropathogen worldwide accounting for 80% of the Urinary Tract Infections (UTIs). Nosocomial infections caused by Multi-drug resistant Gram negative bacteria expressing Extended Spectrum β Lactamase enzyme, pose a serious therapeutic challenge to clinicians due to limited therapeutic options. Stringent adherence to Hospital Antibiotic Policy in treating Urinary Escherichia coli ESBLs is a borne necessity.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom